Tags |
|
|
Links |
|
|
Useful Advices - Five Reasons Why Business Development Is So Difficult To Get Right
Every conversation I have with a CEO of a middle-sized company eventually touches on the same conundrum … ‘How in the world does a company of our size get traction in new markets with new clients?’ This challenge seems to rank right up there with problems of arranging sufficient fi
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nancial resources and getting top people to commit to a small but growing company.
This is often a challenge that did not limit growth in the early stages. During that early growth, the contacts and reputation of the founders and key executives drove the ‘top line’. Most often th
This is often a challenge that did not limit growth in the early stages. During that early growth, the contacts and reputation of the founders and key executives drove the ‘top line’. Most often th
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
client base came to resemble a silo in a corn field … one client dominating the business mix surrounded by other smaller clients that represent stunted attempts at broadening the base.
To be sure, this start up strategy is one of the preferred ways forward during the initial phase
To be sure, this start up strategy is one of the preferred ways forward during the initial phase
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
. In fact it is an early indicator if the management team has any business starting the business at all. If they don’t have ready clients for their product of service, they should get them before going forward.
But why, once the early growth phase is over, is it so difficult to g
But why, once the early growth phase is over, is it so difficult to g
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
t business development going? Why do the business development slots look so much like revolving doors? And, why is it that growing a company from nil to ten or fifteen million in annual revenues often does not seem to prepare management to take it to thirty or fifty million?
Here
Here
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
are some suggestions that might serve to channel discussions towards productive areas.
One: The senior management (particularly the CEO) is not really committed to making the journey. This is more common that you might think. Corporate growth requires significant self-reinventio
One: The senior management (particularly the CEO) is not really committed to making the journey. This is more common that you might think. Corporate growth requires significant self-reinventio
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
n among key members of the senior team. Often they are not prepared to give up control or manage a larger operation. Some prefer ‘writing code’ or whatever the company’s principal business happens to be. But whatever their ‘rationale’, they don’t want to or can’t become managers.
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
In this case, expenditures on business development can just be a waste of resources. Better save the money and buy the new car.
Two: The structure pretty much guarantees failure. Business development is often an afterthought add-on to the evolved organizational structure. It s
Two: The structure pretty much guarantees failure. Business development is often an afterthought add-on to the evolved organizational structure. It s
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
eems to operate in a quasi-independent status with loose reporting arrangements to the CEO or COO. It is an appendage after the fact. Business development has to be integral to the company’s organizational structure and the CEO needs to be the senior business development member of
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
the team. I once attended an all-hands retreat of a company where the COO gave the business development report. That spoke volumes on how the company saw the three business development employees standing in the wings. They were, of course, replaced by newer models by the next ret
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
eat and the revolving door was kept in good working order.
Three: Business development is seen as the province of middle-level people. Think of the message that such an approach gives potential new clients. “Talk to the ‘lessers’ and, if we deem you worthy, we will let you talk
Three: Business development is seen as the province of middle-level people. Think of the message that such an approach gives potential new clients. “Talk to the ‘lessers’ and, if we deem you worthy, we will let you talk
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
to the senior people.” New clients need/want to see the top person right off the get-go. It is the CEO that represents the Company’s commitment to client satisfaction, the ability of the company to commit as well as the ability of the client to find some person to rely on. Each t
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
me a decision-maker chooses to go with a new company they take a huge risk. If it goes wrong … how much faith do you think such a person would put in a middle level person with no real connection to the Company’s culture or senior management team?
Four: The wrong people for the
Four: The wrong people for the
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
job: A company often will bring in ‘business development’ types as a first attempt to attack the problem of widening the client base. These people are ‘specialists’ in chasing business … but frequently not specialists in the business of the company. Most often they are walled-off
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
from the Company’s principal clients and are limited to higher risk longer cycle targets. What is most interesting about this approach is that it resource-starves functions that a company needs to provide in order to successfully grow its top line. Money is spent on business devel
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
pment types while the proposal development, capture team and red-teaming are radically under-resourced. In the end it is often the case of a middle level employee identifying a marginal piece of business that the company cannot properly pursue and capture.
Five: What is all this
Five: What is all this
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
making us look like in the market place? The process is called branding … establishing the reputation of the company in the minds of actual and potential customers. It is by far the least understood and most dangerous threat to any company’s future. How is your company known … wh
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
t is its reputation? How well do you understand why customers do business with you? Are you known as a group that knows how business is done? Or are you branded as a company that has ‘outsourced’ its future? These ‘costs’ are often overlooked as being less important than the bus
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
iness of the business. This mistake has probably killed more companies than any other. How you are known determines how seriously you are taken … and that largely determines what opportunities you will see and how successful you will become.
Business development is a tough nut to
Business development is a tough nut to
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
crack for any management team intent on growing a business out of the teens towards the ‘century’ mark. There are more dead bodies in that field than live travelers. Without careful planning and disciplined execution, the results are likely to be both disappointing and frustrating
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/38353/usefuladvices-Five-Reasons-Why-Business-Development-Is-So-Difficult-To-Get-Right.html">Five Reasons Why Business Development Is So Difficult To Get Right</a>
BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/38353/usefuladvices-Five-Reasons-Why-Business-Development-Is-So-Difficult-To-Get-Right.html]Five Reasons Why Business Development Is So Difficult To Get Right[/url]
Related Articles:
Martial Artist Says They Can Only Hurt You If They Can Reach You!
Biofertilizers to Boost Farm Output
Women - The Key to Making Money in Business
Bookmark it:
|